Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Glioblastoma × pazopanib × Clear all

Phase

Phase 2 3 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 5 Ovarian Neoplasms 4 Neurofibrosarcoma 2 Hemangiosarcoma 2 Vascular Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solitary Fibrous Tumors 1 Solid Tumors 1 Solid Tumor, Adult 1 Smooth Muscle Tumor 1 Sarcoma, Clear Cell 1 Relapsed Pediatric Solid Tumor 1 Osteosarcoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Adipose Tissue 1 Myoepithelioma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Histiocytoma, Angiomatoid Fibrous 1 Histiocytoma 1 Hemangioendothelioma, Epithelioid 1 Granuloma, Plasma Cell 1 Granular Cell Tumor 1 Glomus Tumor 1 Glioblastoma 1 Fibrosarcoma 1 Fallopian Tube Neoplasms 1

Interventions

Temozolomide 65 Radiotherapy 26 Bevacizumab 23 Carboplatin 12 Radiation 11 pembrolizumab 10 Irinotecan 7 Carmustine 7 Surgical Procedures, Operative 6 Radiosurgery 6 Erlotinib Hydrochloride 6 Nivolumab 5 Everolimus 5 temsirolimus 4 atezolizumab 4 Vorinostat 4 Radiotherapy, Intensity-Modulated 4 Lomustine 4 Aminolevulinic Acid 4 tipifarnib 3 fludarabine 3 Sirolimus 3 Radiotherapy, Conformal 3 Paclitaxel 3 Magnetic Resonance Spectroscopy 3 IL13-PE38 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Gemcitabine 3 Drug Therapy 3 Cyclophosphamide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02331498 2025-05-20

PAZOGLIO

Centre Antoine Lacassagne

Phase 1/2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡